Silence Therapeutics reported $98.45M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AstraZeneca USD 17.88B 1.17B Mar/2026
Autolus Therapeutics Ltd USD 38.07M 37.71M Mar/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Silence Therapeutics USD 98.45M 76.27M Dec/2025